Hein C, Pilatz A, Wagenlehner F M E
Klinik für Urologie, Kinderurologie und Andrologie, Justus-Liebig-Universität Gießen, Rudolf-Buchheim-Str. 7, 35392, Gießen, Deutschland.
Urologe A. 2017 Sep;56(9):1109-1115. doi: 10.1007/s00120-017-0433-1.
The use of peri-operative antimicrobial prophylaxis during urological procedures to prevent postoperative complications is very common.
What kind of recommendations for reasonable use of peri-operative antimicrobial prophylaxis during urological procedures to prevent increasing antibiotic resistance and postoperative complications exist?
Review of evidence-based recommendations from literature and current Guidelines of the EAU.
For urological procedures there are evidenced-based recommendations for using antimicrobial prophylaxis, although the evidence is not always sufficiently high. For endourological procedures it is recommended to use Cephalosporines group 2 (or 3), Aminopenicillin/Beta-lactamase inhibitor or Cotrimoxazole. For transrectal core biopsy of the prostate, depending on the risk, Fluoroquinolones, Cotrimoxazole or targeted prophylaxis are recommended. For laparoscopic or open procedures, partly optional, Cephalosporines group 2 (or 3), Aminopenicillin/Beta-lactamase inhibitor or Cotrimoxazole and for a cystectomy with opening of the intestinal tract Cephalosporines group 2 or an Aminopenicillin/Beta-lactamase inhibitor, together with Metronidazole are recommended.
Using prudent peri-operative antimicrobial prophylaxis patient surgical risk factors as well as the expected spectrum of pathogens and the local resistance profile should be considered. Perioperative antibiotic prophylaxis on the one hand aims at preventing postoperative infections, and on the other hand plays an important role in the total antibiotic consumption. It is therefore a pivotal aspect of "Antimicrobial Stewardship" strategies in the health-care system.
泌尿外科手术期间使用围手术期抗菌药物预防术后并发症非常普遍。
对于泌尿外科手术期间合理使用围手术期抗菌药物预防抗生素耐药性增加和术后并发症有哪些建议?
回顾文献中的循证建议和欧洲泌尿外科学会(EAU)的现行指南。
对于泌尿外科手术,有关于使用抗菌药物预防的循证建议,尽管证据水平并非总是足够高。对于腔内泌尿外科手术,建议使用第二代(或第三代)头孢菌素、氨基青霉素/β-内酰胺酶抑制剂或复方新诺明。对于经直肠前列腺穿刺活检,根据风险,建议使用氟喹诺酮类、复方新诺明或针对性预防。对于腹腔镜或开放手术,部分为可选方案,建议使用第二代(或第三代)头孢菌素、氨基青霉素/β-内酰胺酶抑制剂或复方新诺明;对于肠道切开的膀胱切除术,建议使用第二代头孢菌素或氨基青霉素/β-内酰胺酶抑制剂,并联合甲硝唑。
使用围手术期抗菌药物预防时应谨慎考虑患者的手术风险因素以及预期的病原体谱和局部耐药情况。围手术期抗生素预防一方面旨在预防术后感染,另一方面在总抗生素消耗中起重要作用。因此,它是医疗保健系统中“抗菌药物管理”策略的关键方面。